Structure-based screening for discovery of sweet compounds

被引:28
|
作者
Ben Shoshan-Galeczki, Yaron [1 ,2 ]
Niv, Masha Y. [1 ,2 ]
机构
[1] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food & Nutr, IL-76100 Rehovot, Israel
[2] Hebrew Univ Jerusalem, Fritz Haber Ctr Mol Dynam, IL-91904 Jerusalem, Israel
关键词
Sweet taste receptor; Docking; Modeling; Sweeteners; Drug discovery; GPCR; Tas1R2; T1R2; NONCALORIC SWEETENERS; TASTE PERCEPTION; MAMMALIAN SWEET; RECEPTOR; UMAMI; PREDICTION; ASPARTAME; BITTER; SITE;
D O I
10.1016/j.foodchem.2020.126286
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Sweet taste is a cue for calorie-rich food and is innately attractive to animals, including humans. In the context of modern diets, attraction to sweetness presents a significant challenge to human health. Most known sugars and sweeteners bind to the Venus Fly Trap domain of T1R2 subunit of the sweet taste heterodimer. Because the sweet taste receptor structure has not been experimentally solved yet, a possible approach to finding sweet molecules is virtual screening using compatibility of candidate molecules to homology models of sugar-binding site. Here, the constructed structural models, docking and scoring schemes were validated by their ability to rank known sweet-tasting compounds higher than properties-matched random molecules. The best performing models were next used in virtual screening, retrieving recently patented sweeteners and providing novel predictions.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Structure-based screening and design in drug discovery
    van Dongen, M
    Weigelt, J
    Uppenberg, J
    Schultz, J
    Wikström, M
    DRUG DISCOVERY TODAY, 2002, 7 (08) : 471 - 478
  • [2] Virtual screening in structure-based drug discovery
    Barril, X
    Hubbard, RE
    Morley, SD
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (07) : 779 - 791
  • [3] Structure-based screening of low-affinity compounds
    Carr, R
    Jhoti, H
    DRUG DISCOVERY TODAY, 2002, 7 (09) : 522 - 527
  • [4] Ligand docking and virtual screening in structure-based drug discovery
    Cavasotto, Claudio N.
    FROM PHYSICS TO BIOLOGY: THE INTERFACE BETWEEN EXPERIMENT AND COMPUTATION, 2006, 851 : 34 - 49
  • [5] Structure-based high throughput virtual screening for drug discovery
    Jiang, HL
    Shen, JH
    Luo, XM
    Shen, X
    Liu, H
    Cheng, F
    Shen, JK
    Chen, KX
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 283A - 283A
  • [6] Structure-based virtual screening of chemical libraries for drug discovery
    Ghosh, Sutapa
    Nie, Aihua
    An, Jing
    Huang, Ziwei
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2006, 10 (03) : 194 - 202
  • [7] STRUCTURE-BASED HIGH THROUGHPUT VIRTUAL SCREENING FOR DRUG DISCOVERY
    Jiang, H.
    Shen, J.
    Luo, X.
    Liu, H.
    Chen, F.
    Tan, X.
    Shen, J.
    Chen, K.
    Silman, I.
    Sussman, J. L.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C67 - C67
  • [8] Structure-Based Virtual Screening Accelerates GPCR Drug Discovery
    Liu, Lei
    Jockers, Ralf
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (06) : 382 - 384
  • [9] Ligand docking and structure-based virtual screening in drug discovery
    Cavasotto, Claudio N.
    Orry, Andrew J. W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 1006 - 1014
  • [10] Discovery of the first SecA inhibitors using structure-based virtual screening
    Li, Minyong
    Huang, Ying-Ju
    Tai, Phang C.
    Wang, Binghe
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 368 (04) : 839 - 845